Newish Technology (Beijing) Co.,Ltd. Report issue

Government Phase 2

Organization Overview

First Clinical Trial
2018
NCT03432156
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Newish Technology (Beijing) Co., Ltd. | Newish Technology (Beijing) Co.,Ltd.